GT Biopharma's total assets for Q1 2025 were $2.66M, a decrease of -37.19% from the previous quarter. GTBP total liabilities were $3.64M for the fiscal quarter, a -38.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.